Ranjana H. Advani, C. Kelsey, Philippe Armand, Celeste Bello, Cecil M. Benitez, David A. Bond, Weina Chen, Sheen Cherian, Magdalena Czader, Bouthaina Dabaja, Megan E. Daly, Zachary AK Frosch, L. I. Gordon, Neil Hansen, Alex F. Herrera, Ephraim P. Hochberg, Richard T. Hoppe, Iris Isufi, Patrick B. Johnston, Kara M Kelly, Vaishalee P. Kenkre, Justin Kline, R. Lynch, Jonathan McConathy, David Morgan, Alex Niu, Suman Paul, R. Rabinovitch, Ali Salavati, Dahlia Sano, Harsh Shah, Michael A. Spinner, J. Svoboda, Jane N. Winter, Joachim Yahalom, Joanna C. Yang, Sarah Montgomery, Katie Stehman
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Hodgkin lymphoma provide expert, multidisciplinary recommendations for the diagnosis and treatment of Hodgkin lymphoma. The panel convenes annually to update recommendations based on a review of recently published clinical trials. This selection from the NCCN Guidelines for Hodgkin Lymphoma focuses on the management of newly diagnosed and relapsed/refractory classic Hodgkin lymphoma in adults aged 18 to 60 years.